Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04998357 · ClinicalTrials.gov registry record · NA
Autologous Mitochondrial Transplant for Cerebral Ischemia
A NA study of Cerebral Ischemia, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04998357 is a NA study of Cerebral Ischemia that is actively recruiting participants, run by University of Washington. The registered enrollment target is 20 participants, below the 15,140-participant average among 4 other Cerebral Ischemia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04998357, a NA study of Cerebral Ischemia, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.
Conditions Studied
Interventions
- OTHER Endovascular autologous mitochondrial transplantation
Study Locations (1)
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2026-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04998357
The ClinicalTrials.gov registry entry for NCT04998357 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 15,140-participant average among 4 other Cerebral Ischemia trials with a reported enrollment target (100% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cerebral Ischemia appearing as the primary indexed condition, and to 1 intervention - of which Endovascular autologous mitochondrial transplantation is the first listed.
NCT04998357 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT04998357 about?
NCT04998357 is a clinical study titled "Autologous Mitochondrial Transplant for Cerebral Ischemia". The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.
What is the current status of trial NCT04998357?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-04-29. Estimated completion is 2026-10-29.
What conditions does trial NCT04998357 study?
This clinical trial studies the following conditions: Cerebral Ischemia.
What interventions are being tested in trial NCT04998357?
The interventions under investigation include: Endovascular autologous mitochondrial transplantation (OTHER).
Who is sponsoring clinical trial NCT04998357?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04998357 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.